Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.56 USD | +2.70% | -10.89% | +37.95% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 117M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | 12.42M | Net Debt 2025 * | 19.19M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.42
x | P/E ratio 2025 * |
-5.62
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.67% |
Latest transcript on Rani Therapeutics Holdings, Inc.
1 day | +1.67% | ||
1 week | -12.18% | ||
Current month | -29.25% | ||
1 month | -32.63% | ||
3 months | +31.60% | ||
6 months | +125.70% | ||
Current year | +35.96% |
Managers | Title | Age | Since |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Mir Imran
FOU | Founder | 67 | 21-04-05 |
Svai Sanford
DFI | Director of Finance/CFO | 54 | 21-04-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 21-04-05 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 21-04-05 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 4.58 | +3.15% | 83 555 |
24-05-24 | 4.44 | -9.94% | 103,952 |
24-05-23 | 4.93 | -5.92% | 57,375 |
24-05-22 | 5.24 | +1.95% | 39,879 |
24-05-21 | 5.14 | -2.10% | 52,347 |
Delayed Quote Nasdaq, May 28, 2024 at 10:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.96% | 117M | |
+10.49% | 118B | |
+10.59% | 106B | |
-10.61% | 23.4B | |
-1.86% | 22.1B | |
-10.28% | 18.34B | |
-41.92% | 16.59B | |
-14.72% | 15.97B | |
+6.09% | 14.03B | |
+16.60% | 11.67B |
- Stock Market
- Equities
- RANI Stock